李 岡遠

Medicine & Life Sciences

1. Chronic Obstructive Pulmonary Disease 100%
2. Non-Small Cell Lung Carcinoma 58%
3. Air Pollution 56%
4. Lung 48%
5. Lung Neoplasms 46%
6. Particulate Matter 41%
7. Adenocarcinoma of Lung 32%
8. Tuberculosis 29%
9. Asthma 26%
10. Protein-Tyrosine Kinases 25%
11. Emphysema 25%
12. Myeloid-Derived Suppressor Cells 23%
13. Neoplasms 22%
14. Inflammation 21%
15. ErbB Receptors 20%
16. Pulmonary Tuberculosis 18%
17. Interleukin-1 18%
18. Macrophages 18%
19. durvalumab 17%
20. Obstructive Sleep Apnea 17%
21. Pneumonia 17%
22. Pleural Effusion 17%
23. Exercise 15%
24. Therapeutics 15%
25. Interleukin-8 15%
26. Nanoparticles 15%
27. Smooth Muscle Myocytes 14%
28. Survival 14%
29. Leukocyte Elastase 14%
30. Ligands 13%
31. Coronavirus 13%
32. Neutrophils 13%
33. Proteomics 13%
34. Proteins 13%
35. Population 12%
36. Bronchoscopy 12%
37. Mutation 12%
38. Machine Learning 12%
39. Blood Cells 12%
40. Confidence Intervals 12%
41. Sleep 12%
42. T-Lymphocytes 11%
43. Alveolar Epithelial Cells 11%
44. Epiregulin 11%
45. Cohort Studies 11%
46. Smooth Muscle 11%
47. inter-alpha-inhibitor 11%
48. Up-Regulation 11%
49. Lung Injury 10%
50. Biomarkers 10%